Biological properties of potent inhibitors of class I phosphatidylinositide 3-kinases: from PI-103 through PI-540, PI-620 to the oral agent GDC-0941.
作者:
主题词
投药, 口服(Administration, Oral);动物(Animals);细胞增殖(Cell Proliferation);细胞, 培养的(Cells, Cultured);内皮, 血管(Endothelium, Vascular);酶抑制剂(Enzyme Inhibitors);女(雌)性(Female);呋喃类(Furans);胶质母细胞瘤(Glioblastoma);人类(Humans);吲唑类(Indazoles);小鼠(Mice);小鼠, 近交BALB C(Mice, Inbred BALB C);小鼠, 裸(Mice, Nude);分子结构(Molecular Structure);卵巢肿瘤(Ovarian Neoplasms);磷酸肌醇3-激酶类(Phosphatidylinositol 3-Kinases);蛋白激酶类(Protein Kinases);吡啶类(Pyridines);嘧啶类(Pyrimidines);磺胺类(Sulfonamides);TOR丝氨酸-苏氨酸激酶(TOR Serine-Threonine Kinases);噻吩类(Thiophenes);脐静脉(Umbilical Veins);异种移植模型抗肿瘤试验(Xenograft Model Antitumor Assays)
DOI
10.1158/1535-7163.MCT-08-1200
PMID
19584227
发布时间
2021-12-03
- 浏览7

Molecular cancer therapeutics
1725-38页
相似文献
- 中文期刊
- 外文期刊
- 学位论文
- 会议论文